Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of RNA helicase DHX33 inhibitor in preparation of medicine for treating liver cancer

An RNA helicase, a technology for the treatment of liver cancer, applied in the field of biomedicine, can solve the problems of lack of targets and inhibitors for liver cancer, difficulties, and the increase of human liver cancer research and development targets, and achieve important medical development value and the effect of treating liver cancer

Active Publication Date: 2021-09-17
SHENZHEN KEYE HEALTH CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The reason is that hepatocellular carcinoma does not have clear driver genes or biomarkers like lung cancer, which makes it very difficult to develop new drug targets for human liver cancer
In addition to immune checkpoint inhibitors, various inhibitors for various cancer targets, such as various growth factor receptors, C-MET and other inhibitors are in progress, but the overall treatment of liver cancer is still lack of effective targets and inhibitors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of RNA helicase DHX33 inhibitor in preparation of medicine for treating liver cancer
  • Application of RNA helicase DHX33 inhibitor in preparation of medicine for treating liver cancer
  • Application of RNA helicase DHX33 inhibitor in preparation of medicine for treating liver cancer

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0054] The present invention also provides a method for preparing the lentivirus, comprising the following steps:

[0055] Use Lipofectamine 2000 (Life Technologies) liposome introduction method to transfect the plasmid mixture in 293T cells: the specific operation method is to use a cell culture dish with a diameter of 10 cm for transfection, and when the 293T cells grow to 90% confluence, the The following plasmids were mixed, including pLKO.1-shRNA (that is, the above lentiviral plasmid), pCMV-VSV-G, pCMV-dR8.2 dvpr, and the ratio of plasmid mixing was 9:8:1, so that the total DNA amount reached each Petri dish 12μg. Among them, the vectors pLKO.1, pCMV-VSV-G, pCMV-dR8.2 dvpr were purchased from Biovector Inc.

[0056] After 16-18h, it was changed to medium containing antibiotics (penicillin and streptomycin), and after another 24h or 48h, the cell culture medium was collected with a sterile pipette, centrifuged at 1000rpm for two minutes, and the virus was repacked in 5mL...

Embodiment 1

[0150] Example 1 DHX33 protein plays an important role in hepatoma cells, and gene silencing of DHX33 significantly inhibits the growth of human hepatoma cells in vitro and in vivo

[0151] 1. Immunohistochemical analysis of the expression of DHX33 protein in human hepatocellular carcinoma tissues

[0152] Microarrays of paraffin tissue sections of human liver cancer tissues were purchased from US BIOMAX Company, including 40 different liver cancer tissues in total, and three normal liver tissues were used as normal tissue controls. Paraffin-embedded tissue chips were first incubated in a 60°C oven for 30 minutes, then rapidly deparaffinized in xylene and gradually decreased at a range of ethanol concentrations (100%, 95%, 70%, 50%, and 25%). The solution was gradually hydrated (5 minutes of gentle shaking each time, and the treatment of each concentration of ethanol solution was repeated once), and the hydration was continued in distilled water for 10 minutes. Antigens were ...

Embodiment 2

[0162] Example 2 DHX33 regulates de novo cholesterol production in human hepatoma cells by regulating the transcription of various genes in the mevalonate pathway

[0163] Cell growth is inseparable from the synthesis of cell membranes, especially in cancer cells, the efficiency of membrane formation is significantly improved. Studies have shown that in liver cancer cells, the mevalonate pathway is abnormally active. The mevalonate pathway is an important biosynthetic route to generate cholesterol. It not only provides an important membrane component-cholesterol, but also can synthesize a variety of intermediates such as Endoyl lipid molecules, etc., promote the activation of various oncogenes, such as the farendylation of RAS protein, a lipid coupling reaction can activate RAS in the inner membrane. Therefore, the mevalonate pathway is an important factor in promoting the occurrence and development of cancer. If the important genes of this pathway are inhibited, studies have ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of biological medicine, and discloses application of an RNA helicase DHX33 inhibitor in preparation of a medicine for treating liver cancer. According to the application of the RNA helicase DHX33 inhibitor in preparation of the medicine for treating the liver cancer, the important effect of DHX33 protein in occurrence and development of the liver cancer is determined, and the provided small molecule compound has the effect of inhibiting activity of DHX33 helicase, so that synthesis of mevalonic acid regulated and controlled by DHX33 is inhibited. The small molecule compound can significantly inhibit the growth of liver cancer cells in vitro and in vivo, and has important medical development value.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to the application of an RNA helicase DHX33 inhibitor in the preparation of a medicine for treating liver cancer. Background technique [0002] China is one of the countries with a high incidence of liver cancer. According to the statistics of the World Health Organization, in 2020, a total of 410,000 people in China were diagnosed with liver cancer, and the death cases caused by liver cancer reached as many as 390,000, and the incidence and fatality rates were almost the same. Nationally, more than 70% of liver cancers are related to viral infections, especially hepatitis B virus (HBV) infection. [0003] There are various treatment methods for liver cancer, including surgery and targeted therapy, but currently, surgical treatment represented by liver resection is still the preferred treatment for liver cancer. In the molecular targeted therapy of liver cancer, sorafenib is currently t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/437A61P35/00A61P35/04
CPCA61K45/00A61K31/437A61P35/00A61P35/04A61K2300/00
Inventor 张严冬李相鲁
Owner SHENZHEN KEYE HEALTH CO LTD